“…Vascular smooth muscle cell plasticity in CVD, including atherosclerosis, has been well-documented [2]. Especially in the past decade, the emergence of new technologies, such as lineage tracing, single-cell RNA sequencing (scRNA-Seq), and spatial transcriptomics [18][19][20][21], has largely extended our knowledge of cell origin, characteristics, and transcriptomic profiles in the atherosclerotic lesions. Under pathological conditions, VSMCs transdifferentiate into various cell types such as foam cells [22,23], mesenchymal-stem-cell (MSC)-like cells [24], macrophage-like cells [25,26], adipocyte-like cells [27], osteochondrogenic cells [28,29], fibromyocytes [19].…”